Brawn Biotech Faces Intense Selling Pressure Amid Significant Price Declines
Brawn Biotech Ltd is experiencing notable selling pressure, with consecutive days of losses and a significant decline over the past month. The stock's performance contrasts sharply with the Sensex, reflecting broader market challenges and potential concerns regarding the company's financial health, as it remains below key moving averages.
Brawn Biotech Ltd is currently facing significant selling pressure, with today's trading session showing only sellers in the market. The stock has experienced consecutive days of losses, reflecting a broader trend of declining performance. Over the past month, Brawn Biotech has dropped by 16.75%, while the Sensex has gained 3.60%, highlighting a stark contrast in performance.In the short term, Brawn Biotech's one-day performance shows a decline of 3.57%, even as the Sensex fell by only 0.93%. This trend continues over the week, with the stock down 0.57% compared to the Sensex's increase of 2.44%. Over the last three months, Brawn Biotech has lost 27.53%, while the Sensex has seen a modest decline of 1.51%.
Several factors may be contributing to this selling pressure, including market sentiment and potential concerns regarding the company's financial health. The stock's performance relative to key moving averages indicates it is currently below the 20-day, 50-day, 100-day, and 200-day averages, suggesting a bearish trend. Overall, Brawn Biotech's performance remains under scrutiny as it continues to face challenges in the trading landscape.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
